Chung, S. J., Miller, R. A., Permpalung, N., Baker, A. W., Diehl, L. F., Rizzieri, D. A., & Alexander, B. D. (2019). Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience. Leuk Lymphoma, 60(2), 488–492. https://doi.org/10.1080/10428194.2018.1488252

Chung, Shimin Jasmine, Rachel Ann Miller, Nitipong Permpalung, Arthur Wakefield Baker, Louis Frederic Diehl, David Alan Rizzieri, and Barbara Dudley Alexander. “Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience.” Leuk Lymphoma 60, no. 2 (February 2019): 488–92. https://doi.org/10.1080/10428194.2018.1488252.

Chung SJ, Miller RA, Permpalung N, Baker AW, Diehl LF, Rizzieri DA, et al. Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience. Leuk Lymphoma. 2019 Feb;60(2):488–92.

Chung, Shimin Jasmine, et al. “Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience.” Leuk Lymphoma, vol. 60, no. 2, Feb. 2019, pp. 488–92. Pubmed, doi:10.1080/10428194.2018.1488252.

Chung SJ, Miller RA, Permpalung N, Baker AW, Diehl LF, Rizzieri DA, Alexander BD. Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience. Leuk Lymphoma. 2019 Feb;60(2):488–492.